[
    {
        "title": "Is Apellis Pharmaceuticals Inc (APLS) a Winner in the Biotechnology Industry? - InvestorsObserver",
        "description": "Is Apellis Pharmaceuticals Inc (APLS) a Winner in the Biotechnology Industry?  InvestorsObserver",
        "published date": "Tue, 17 Oct 2023 16:08:01 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmludmVzdG9yc29ic2VydmVyLmNvbS9uZXdzL3N0b2NrLXVwZGF0ZS9pcy1hcGVsbGlzLXBoYXJtYWNldXRpY2Fscy1pbmMtYXBscy1hLXdpbm5lci1pbi10aGUtYmlvdGVjaG5vbG9neS1pbmR1c3RyedIBggFodHRwczovL3d3dy5pbnZlc3RvcnNvYnNlcnZlci5jb20vbmV3cy9zdG9jay11cGRhdGUvYW1wL2lzLWFwZWxsaXMtcGhhcm1hY2V1dGljYWxzLWluYy1hcGxzLWEtd2lubmVyLWluLXRoZS1iaW90ZWNobm9sb2d5LWluZHVzdHJ5?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.investorsobserver.com",
            "title": "InvestorsObserver"
        }
    },
    {
        "title": "How Much Upside is Left in Apellis Pharmaceuticals, Inc. (APLS)? Wall Street Analysts Think 67.65% - Yahoo Finance",
        "description": "How Much Upside is Left in Apellis Pharmaceuticals, Inc. (APLS)? Wall Street Analysts Think 67.65%  Yahoo Finance",
        "published date": "Tue, 10 Oct 2023 13:55:08 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tdWNoLXVwc2lkZS1sZWZ0LWFwZWxsaXMtcGhhcm1hY2V1dGljYWxzLTEzNTUwODIyOC5odG1s0gFeaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvbXVjaC11cHNpZGUtbGVmdC1hcGVsbGlzLXBoYXJtYWNldXRpY2Fscy0xMzU1MDgyMjguaHRtbA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "B of A Securities Maintains Apellis Pharmaceuticals (APLS) Neutral ... - Nasdaq",
        "description": "B of A Securities Maintains Apellis Pharmaceuticals (APLS) Neutral ...  Nasdaq",
        "published date": "Fri, 13 Oct 2023 06:49:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYi1vZi1hLXNlY3VyaXRpZXMtbWFpbnRhaW5zLWFwZWxsaXMtcGhhcm1hY2V1dGljYWxzLWFwbHMtbmV1dHJhbC1yZWNvbW1lbmRhdGlvbi0w0gEA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.nasdaq.com",
            "title": "Nasdaq"
        }
    },
    {
        "title": "Is Apellis Pharmaceuticals Inc (APLS) Stock at the Top of the Biotechnology Industry? - InvestorsObserver",
        "description": "Is Apellis Pharmaceuticals Inc (APLS) Stock at the Top of the Biotechnology Industry?  InvestorsObserver",
        "published date": "Thu, 05 Oct 2023 13:38:11 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiAFodHRwczovL3d3dy5pbnZlc3RvcnNvYnNlcnZlci5jb20vbmV3cy9zdG9jay11cGRhdGUvaXMtYXBlbGxpcy1waGFybWFjZXV0aWNhbHMtaW5jLWFwbHMtc3RvY2stYXQtdGhlLXRvcC1vZi10aGUtYmlvdGVjaG5vbG9neS1pbmR1c3RyeS030gGMAWh0dHBzOi8vd3d3LmludmVzdG9yc29ic2VydmVyLmNvbS9uZXdzL3N0b2NrLXVwZGF0ZS9hbXAvaXMtYXBlbGxpcy1waGFybWFjZXV0aWNhbHMtaW5jLWFwbHMtc3RvY2stYXQtdGhlLXRvcC1vZi10aGUtYmlvdGVjaG5vbG9neS1pbmR1c3RyeS03?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.investorsobserver.com",
            "title": "InvestorsObserver"
        }
    },
    {
        "title": "JP Morgan Upgrades Apellis (NASDAQ:APLS) after Impressive Q3 ... - TipRanks",
        "description": "JP Morgan Upgrades Apellis (NASDAQ:APLS) after Impressive Q3 ...  TipRanks",
        "published date": "Fri, 06 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2pwLW1vcmdhbi11cGdyYWRlcy1hcGVsbGlzLW5hc2RhcWFwbHMtYWZ0ZXItaW1wcmVzc2l2ZS1xMy1yZXN1bHRz0gEA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.tipranks.com",
            "title": "TipRanks"
        }
    },
    {
        "title": "Apellis (APLS) Provides Syfovre Q3 Preliminary Revenues Guidance - Yahoo Finance",
        "description": "Apellis (APLS) Provides Syfovre Q3 Preliminary Revenues Guidance  Yahoo Finance",
        "published date": "Fri, 06 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hcGVsbGlzLWFwbHMtcHJvdmlkZXMtc3lmb3ZyZS1xMy0xMzU0MDAzNDguaHRtbNIBVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2FwZWxsaXMtYXBscy1wcm92aWRlcy1zeWZvdnJlLXEzLTEzNTQwMDM0OC5odG1s?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "Why Shares of Apellis Pharmaceuticals Were Down Wednesday - The Motley Fool",
        "description": "Why Shares of Apellis Pharmaceuticals Were Down Wednesday  The Motley Fool",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA5LzI3L3doeS1zaGFyZXMtb2YtYXBlbGxpcy1waGFybWFjZXV0aWNhbHMtd2VyZS1kb3duLXdlL9IBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.fool.com",
            "title": "The Motley Fool"
        }
    },
    {
        "title": "Interesting APLS Put And Call Options For December 1st - Nasdaq",
        "description": "Interesting APLS Put And Call Options For December 1st  Nasdaq",
        "published date": "Thu, 12 Oct 2023 15:50:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvaW50ZXJlc3RpbmctYXBscy1wdXQtYW5kLWNhbGwtb3B0aW9ucy1mb3ItZGVjZW1iZXItMXN00gEA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.nasdaq.com",
            "title": "Nasdaq"
        }
    },
    {
        "title": "Apellis Pharmaceuticals Inc (APLS) is up 5.32% Tuesday In Premarket Trading - InvestorsObserver",
        "description": "Apellis Pharmaceuticals Inc (APLS) is up 5.32% Tuesday In Premarket Trading  InvestorsObserver",
        "published date": "Tue, 19 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmludmVzdG9yc29ic2VydmVyLmNvbS9uZXdzL3N0b2NrLXVwZGF0ZS9hcGVsbGlzLXBoYXJtYWNldXRpY2Fscy1pbmMtYXBscy1pcy11cC01LTMyLXR1ZXNkYXktaW4tcHJlbWFya2V0LXRyYWRpbmfSAYABaHR0cHM6Ly93d3cuaW52ZXN0b3Jzb2JzZXJ2ZXIuY29tL25ld3Mvc3RvY2stdXBkYXRlL2FtcC9hcGVsbGlzLXBoYXJtYWNldXRpY2Fscy1pbmMtYXBscy1pcy11cC01LTMyLXR1ZXNkYXktaW4tcHJlbWFya2V0LXRyYWRpbmc?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.investorsobserver.com",
            "title": "InvestorsObserver"
        }
    },
    {
        "title": "Interesting APLS Put And Call Options For January 2026 - Nasdaq",
        "description": "Interesting APLS Put And Call Options For January 2026  Nasdaq",
        "published date": "Mon, 18 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvaW50ZXJlc3RpbmctYXBscy1wdXQtYW5kLWNhbGwtb3B0aW9ucy1mb3ItamFudWFyeS0yMDI20gEA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.nasdaq.com",
            "title": "Nasdaq"
        }
    }
]